Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
A side-by-side editorial comparison of ManageEngine RecoveryManager Plus and sdtm.oak — release velocity, themes, recent moves, and the top alternatives to consider.
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
RecoveryManager Plus is a backup-and-recovery tool for Active Directory and Microsoft 365, and it is the most feature-active of the ManageEngine set here. Recent builds add real backup coverage — AD sites and subnets, Entra ID local admin passwords, S3-compatible repositories, SIEM audit forwarding, and Entra ID BitLocker recovery keys — alongside CVE patches and RemCom agent hardening. Build 6322 is the quietest of the run: a single fix for restarts triggered by an outdated ExchangeOnlineManagement PowerShell module during Microsoft 365 enumeration.
Read the full ManageEngine RecoveryManager Plus trajectory →
Two releases in, the open-source SDTM toolkit now covers the domains it originally excluded.
sdtm.oak builds SDTM datasets — the tabulation standard clinical trial submissions are filed in — from raw collected data. The 0.1.0 release shipped the mapping algorithm functions and derived-variable helpers but explicitly excluded DM, trial design domains, and several others. Version 0.2.0 closes the largest of those gaps, adding DM domain support via calc_min_max_date() and oak_calc_ref_dates(), plus generate_sdtm_supp() for supplemental qualifier domains.
RecoveryManager Plus is a backup-and-recovery tool for Active Directory and Microsoft 365, and it is the most feature-active of the ManageEngine set here. Recent builds add real backup coverage — AD sites and subnets, Entra ID local admin passwords, S3-compatible repositories, SIEM audit forwarding, and Entra ID BitLocker recovery keys — alongside CVE patches and RemCom agent hardening. Build 6322 is the quietest of the run: a single fix for restarts triggered by an outdated ExchangeOnlineManagement PowerShell module during Microsoft 365 enumeration.
The direction is coverage expansion: methodically extending what can be backed up and restored across on-prem AD and Entra ID, while broadening cloud storage targets and operational integrations. The dependence on Microsoft's own PowerShell modules is the cost of that coverage, and 6322 shows where it bites — a stale module on the customer's side takes the product down mid-enumeration. Feature builds and pure-fix builds alternate at roughly a two-month cadence, so a single-issue build reads as a gap between feature cycles rather than a slowdown.
Expect continued expansion of Entra ID and cloud-native backup coverage and more storage-target options, with security patches folded into each build; the next build carrying a Features section is due on the cadence this feed has held.
sdtm.oak builds SDTM datasets — the tabulation standard clinical trial submissions are filed in — from raw collected data. The 0.1.0 release shipped the mapping algorithm functions and derived-variable helpers but explicitly excluded DM, trial design domains, and several others. Version 0.2.0 closes the largest of those gaps, adding DM domain support via calc_min_max_date() and oak_calc_ref_dates(), plus generate_sdtm_supp() for supplemental qualifier domains.
This is the pharmaverse pattern of building submission tooling in the open, one domain class at a time, with the release history running through GitHub release-candidate tags before each CRAN submission. The direction is clear from the domain checklist: start with the mechanically simple Findings and Events domains, then work toward the ones with cross-dataset dependencies. DM and SUPP were the two that most often forced teams back to bespoke code.
The remaining exclusions from the 0.1.0 scope — trial design domains, SV, SE, RELREC and the EPOCH variable — are the obvious next targets, with EPOCH likely first since it depends on the reference dates 0.2.0 just added. Expect the same rhythm of release candidates ahead of each CRAN submission.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ManageEngine RecoveryManager Plus or sdtm.oak.
Omni ships weekly, and almost every week the headline item is an AI feature.
silx settles into maintenance a release after its PySide6 migration
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
See all ManageEngine RecoveryManager Plus alternatives → · See all sdtm.oak alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. ManageEngine RecoveryManager Plus is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. ManageEngine RecoveryManager Plus is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top ManageEngine RecoveryManager Plus alternatives in Analytics are ranked by recent ship velocity. Browse the "ManageEngine RecoveryManager Plus alternatives" section above for the current picks, or visit /alternatives/manageengine-recoverymanager-plus for the full list with editorial commentary on each.
Top sdtm.oak alternatives in Analytics are ranked by recent ship velocity. Browse the "sdtm.oak alternatives" section above for the current picks, or visit /alternatives/sdtm-oak for the full list with editorial commentary on each.